Our Mission

Advancing Spine Surgery, One Patient at a Time

Pressio Spine was founded to bridge the gap between clinical potential and patient outcomes. We engineer fixation platforms built for the modern operative environment—combining the objective requirements of fusion biology with the logistical demands of the ambulatory setting. By providing surgeons with implants they can trust and a workflow designed for the way surgery is done today, we ensure that technological advancement translates directly to the patient level.

About Pressio

Fixation Built for the Ambulatory Era

Pressio Spine is a clinical fixation platform engineered for the shift to outpatient spine surgery. By pairing continuous-compression Nitinol implants with a sterile, single-use kit model, we deliver exactly what the ambulatory surgery center (ASC) demands: superior fusion biology, improved facility economics, and a workflow that removes operational friction.

Headquartered in Memphis and led by orthopedic operators with over 100 years of combined clinical experience, Pressio is currently commercializing the CONTINUUM™ ACDF fixation system and the TIDAL Technology™ interbody platform. Beyond our cleared portfolio, we are advancing a broader pipeline of Nitinol-based fixation solutions designed to create a new standard for spinal stability and procedural efficiency.

Governance

Leadership Team

Kent Ellington, MD, MS, FAAOS

Chief Executive Officer

Kent Ellington is Co-Founder and CEO of Pressio Spine, a board-certified orthopedic surgeon, inventor, and med-tech leader with extensive experience developing musculoskeletal technologies. He has led the company from concept to commercial launch, developed over 100 products generating $1.5 billion in sales, published 60+ peer-reviewed papers, and served as a physician for elite athletes in the NBA, NFL and MLB.

Governance

Board of Directors

Michael Porter, MBA

Board Member

Michael Porter is the former CEO and co-founder of Covis Group, where he built and led a global pharmaceutical platform from whiteboard concept to more than $1.5 billion in distributed profits across three monetization events, including 10x and 4x cash-on-cash returns. Michael executed 23 M&A transactions while scaling Covis into a top-10 global respiratory franchise selling into 50+ countries. He has 25+ years of private equity, capital markets, restructuring, M&A, and operating leadership experience across LifeSciences and other sectors. Michael currently serves on multiple MedTech boards including early commercial and pre-IPO companies, a Nasdaq listed Commodities & Critical Minerals platform, and previously served as Chairman of a clinical-stage biopharmaceutical company. He brings Pressio deep experience in scaling healthcare platforms, AI implementation, financing strategy, governance and strategic exit preparation.

Jeremy Blair, MBA

Board Member

Healthcare executive with extensive experience in orthopedic device product R&D, commercialization and business development. Proven medtech innovation leadership in early stage startups from pre-revenue through successful acquisition and scaling novel portfolios to $100mm+ revenue. Deep expertise in product development, portfolio strategy, surgeon adoption, and market development.

Guy Guglielmino

Board Member

Veteran MedTech executive with a proven record of accelerating growth and commercial transformation. Most recently CCO at Treace Medical Concepts, he previously served as President of Recovery Sciences at Enovis (Full P&L) and held leadership roles at Wright Medical and Bausch + Lomb. He is a specialist in ASC site-of-care strategies and driving procedural adoption within competitive orthopedic markets.